Skip to content
ppharmaranks
Menu
Class IIOngoing

METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG recall

FDA recall D-0292-2025 · initiated Feb 25, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Apr 2, 2025How we research

A-S Medication Solutions LLC recalled METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG in Feb 2025 — an FDA Class II recall (D-0292-2025) because Presence of Foreign Tablets/Capsules.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Foreign Tablets/Capsules.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot# 4260340; Exp.12/31/2025.

Quantity recalled: 411 180-count bottles

Details

Product
METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3.
Recalling company
A-S Medication Solutions LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in U.S.
Initiated
Feb 25, 2025
FDA report date
Apr 2, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG recalled?
A-S Medication Solutions LLC recalled METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG in Feb 2025 — an FDA Class II recall (D-0292-2025) because Presence of Foreign Tablets/Capsules. May cause temporary or medically reversible harm; low probability of serious harm.
Why was METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG recalled?
Per the FDA enforcement record, the reason for recall D-0292-2025 was: Presence of Foreign Tablets/Capsules.
Is a recalled METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG are affected?
Distributed: Nationwide in U.S.. The recall covers these lots — Lot# 4260340; Exp.12/31/2025.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0292-2025.

Source: openFDA Drug Enforcement record D-0292-2025

← All drug recalls